MG, W., I, A., F, S., K, Y., MR, M., & DF, S. (2026). Antimicrobial activity of ceftolozane/tazobactam, imipenem/relebactam, and comparators against Gram-negative pathogens collected in Arabian Gulf countries: SMART 2020-2024. Frontiers in cellular and infection microbiology, 16, 1827575. https://doi.org/10.3389/fcimb.2026.1827575
Chicago Style (17th ed.) CitationMG, Wise, Alekseeva I, Siddiqui F, Young K, Motyl MR, and Sahm DF. "Antimicrobial Activity of Ceftolozane/tazobactam, Imipenem/relebactam, and Comparators Against Gram-negative Pathogens Collected in Arabian Gulf Countries: SMART 2020-2024." Frontiers in Cellular and Infection Microbiology 16 (2026): 1827575. https://doi.org/10.3389/fcimb.2026.1827575.
MLA (9th ed.) CitationMG, Wise, et al. "Antimicrobial Activity of Ceftolozane/tazobactam, Imipenem/relebactam, and Comparators Against Gram-negative Pathogens Collected in Arabian Gulf Countries: SMART 2020-2024." Frontiers in Cellular and Infection Microbiology, vol. 16, 2026, p. 1827575, https://doi.org/10.3389/fcimb.2026.1827575.